Companies / Xellar Biosystems
Xellar Biosystems
Boston, United States
Xellar Biosystems develops and provides an organ-on-chip platform for predictive drug discovery
Xellar Biosystems, based in Boston, United States, has 1 investor on file, among them Qingsong Fund. Its latest round on record is Series A, 30 Jun 2026, of 2 rounds. Its site was last checked 13 Nov 2026: site answers.
Funding
2 rounds on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Qingsong Fund
9 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (25%), Industrial & Manufacturing (25%), Robotics & Hardware (13%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Xellar Biosystems and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Qingsong Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/xellarbio.com/investors
# also
GET /v1/companies/xellarbio.com
GET /v1/companies/xellarbio.com/news